FibroGen, Inc.
Nitrogen-containing heteroaryl compounds and methods of use thereof
Last updated:
Abstract:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
Status:
Grant
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
25 Jan 2022